{
  "primary": "ATXN3",
  "interaction_type": "indirect",
  "upstream_interactor": "KEAP1",
  "mediator_chain": [
    "KEAP1"
  ],
  "depth": 2,
  "support_summary": "ATXN3 stabilizes KEAP1, the primary negative regulator of NRF2, thereby indirectly suppressing the NRF2-mediated antioxidant response.",
  "functions": [
    {
      "function": "Antioxidant Gene Transcription",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 knockdown reduces the half-life of KEAP1, which is the substrate adaptor for the CUL3 E3 ubiquitin ligase complex that targets the transcription factor NRF2 for degradation.",
      "effect_description": "By stabilizing KEAP1, ATXN3 indirectly suppresses the NRF2-mediated antioxidant response. Under normal conditions, KEAP1 binds to NRF2 in the cytoplasm, leading to its continuous ubiquitination and proteasomal degradation, thus keeping the antioxidant response off.",
      "biological_consequence": [
        "ATXN3 stabilizes KEAP1 → KEAP1 binds to NRF2 → NRF2 is ubiquitinated by the KEAP1-CUL3 E3 ligase complex → Proteasomal degradation of NRF2 → Repression of NRF2 target genes (antioxidant enzymes)"
      ],
      "specific_effects": [
        "The KEAP1-NRF2 pathway is a central regulator of the cellular response to oxidative stress.",
        "Under basal conditions, KEAP1 targets NRF2 for proteasomal degradation.",
        "Activation of the NRF2 pathway involves the dissociation of the NRF2-KEAP1 complex, allowing NRF2 to translocate to the nucleus and activate antioxidant response element (ARE)-containing genes."
      ],
      "evidence": [
        {
          "paper_title": "The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases",
          "year": 2016,
          "pmid": "28510041"
        },
        {
          "paper_title": "Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke",
          "year": 2011,
          "pmid": "21646410"
        }
      ],
      "_context": {
        "type": "direct",
        "query_protein": null,
        "chain": null
      },
      "interaction_effect": "inhibits",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "28510041",
        "21646410"
      ],
      "direct_arrow": "inhibits",
      "function_effect": "inhibition",
      "arrow_context": {
        "direct_from": "KEAP1",
        "direct_arrow": "inhibits",
        "net_from": "ATXN3",
        "net_arrow": "inhibits",
        "mediator_chain": [
          "KEAP1"
        ],
        "is_indirect": true
      },
      "net_arrow": "inhibits",
      "net_effect": "inhibition",
      "direct_effect": "inhibition"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "_validation_status": "rejected",
  "mechanism": "ATXN3 knockdown reduces the half-life of KEAP1, which is the substrate adaptor for the CUL3 E3 ubiquitin ligase complex that targets the transcription factor NRF2 for degradation.",
  "effect": "By stabilizing KEAP1, ATXN3 indirectly suppresses the NRF2-mediated antioxidant response. Under normal conditions, KEAP1 binds to NRF2 in the cytoplasm, leading to its continuous ubiquitination and proteasomal degradation, thus keeping the antioxidant response off.",
  "summary": "ATXN3 inhibits NRF2 to modulate antioxidant gene transcription, ultimately affecting repression of nrf2 target genes (antioxidant enzymes).",
  "evidence": [
    {
      "paper_title": "The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases",
      "year": 2016
    },
    {
      "paper_title": "Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke",
      "year": 2011
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "KEAP1 --inhibits--> NRF2:",
  "protein_a": "NRF2",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-24T12:52:47.833679Z",
  "last_updated": "2025-11-24T12:52:47.833679Z"
}